| Product Name | Tandospirone-d8 |
| Product Code | DA-T211-c |
| Chemical name | Tandospirone-d8 |
| Synonyms | (3aR,4S,7R,7aS)-rel-Hexahydro-2-[4-[4-(2-pyrimidinyl)-1-(piperazinyl-d8)]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione; (3aα,4β,7β,7aα)-Hexahydro-2-[4-[4-(2- pyrimidinyl)-1-(piperazinyl-d8)]butyl]-4,7-methano-1H-isoindole-1,3(2H)-dione; |
| Impurity | NA |
| CAS Number | 1794835-73-6 |
| Alternate CAS # | NA |
| Molecular form | C21H21D8N5O2 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 391.54 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | aromatics,heterocycles,stable isotopes,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Labelled Tandospirone. Tandospirone is a 5HT1A receptor partial agonist. Studies indicate that tandospirone significantly reduces haloperidol-induced bradykinesia in a dose dependent manner. The potency of Tandospirone is equal to that of buspirone and approximate one-half that of diazepam. The potency of Tandospirone at dopamine antagonistic action is less than 1/4 that of buspirone. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
